Vycor Medical (VYCO) Receivables (2010 - 2026)

Vycor Medical (VYCO) has reported Receivables for 17 consecutive years, with $202447.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables changed 0.11% year-over-year to $202447.0 in Q2 2026; TTM through Jun 2026 was $202447.0, a 0.11% change from a year earlier, with the FY2025 full-year figure at $218891.0, down 10.75% from the prior year.
• Receivables was $202447.0 for Q2 2026 at Vycor Medical, up from $194041.0 in the prior quarter.
• Over five years, Receivables peaked at $326052.0 in Q3 2025 and troughed at $156204.0 in Q4 2022.
• A 5-year average of $222014.4 and a median of $217061.0 in 2023 frame the typical range for Receivables.
• Across the five-year window, Receivables surged 41.38% in 2023 and decreased 19.82% in 2025, its largest moves.
• Over 5 years, Receivables stood at $156204.0 in 2022, then surged by 37.79% to $215231.0 in 2023, then climbed by 13.95% to $245260.0 in 2024, then fell by 10.75% to $218891.0 in 2025, then decreased by 7.51% to $202447.0 in 2026.
• The last three Receivables figures came in at $202447.0 (Q2 2026), $194041.0 (Q1 2026), and $218891.0 (Q4 2025), per Business Quant data.